Dermatomyositis: Myositis-specific autoantibodies and skin manifestations-Reference-Cited by-同舟云学术

Dermatomyositis: Myositis-specific autoantibodies and skin manifestations

Published:2012-05 Issue:2 Volume:3 Page:74-84
ISSN:1759-1961
Container-title:Clinical and Experimental Neuroimmunology
language:en
Short-container-title:Clin. Exp. Neuroimmunol.

Author:

Fujimoto Manabu¹

Affiliation:

1. Department of Dermatology; Faculty of Medicine; Institute of Medical, Pharmaceutical and Health Sciences; Kanazawa University; Kanazawa; Ishikawa; Japan

Publisher

Wiley

Subject

Neurology (clinical),Immunology and Microbiology (miscellaneous),Immunology,Neuroscience (miscellaneous)

Reference85 articles.

1. Pathogenesis, classification and treatment of inflammatory myopathies;Zong;Nat Rev Rheumatol,2011

2. Polymyositis and dermatomyositis;Dalakas;Lancet,2003

3. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?;Sontheimer;J Am Acad Dermatol,2002

4. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis;Mammen;Ann N Y Acad Sci,2010

5. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression;Gunawardena;Rheumatology (Oxford),2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A typical case of Dermatomyositis;Journal of Dermatology & Cosmetology;2024-03-05

2. A Case in Which Breast Cancer Developed at the Same Time As Dermatomyositis, and the Onset of New Cancer Was Able to Be Predicted by the Exacerbating Skin Symptoms and Parallel Increase in the Anti-TIF1-γ Antibody Levels;Internal Medicine;2023-10-15

3. Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results;BMC Rheumatology;2020-07-20

4. Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis;Journal of Dermatological Science;2016-12

5. Recent advances in dermatomyositis-specific autoantibodies;Current Opinion in Rheumatology;2016-11